CD79A and cystic fibrosis: Reactivity against the native counterpart of CCP (anti-CAP) was, compared with HC, increased in RA patients for IgG anti-CAP (p < 0.01) and in CF patients for IgA anti-CAP (p < 0.05), although this was not necessarily reflected in increased seropositivity (Fig. 2).